# Nitroglycerin

## Millisrol inj 5mg/10mL

| TAH Drug Code      | [IMIL](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=IMIL)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
|:-------------------|:------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Control of peri-op hypertension; CHF associated with acute MI. Treatment of angina pectoris unresponsive to recommended doses of organic nitrates &/or a Î²- blocker. Production of controlled hypotension during neurosurgical & orthopedic surgical procedures.                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| Dosing             | Diluted to 0.005-0.05% (50-500 mcg/mL), IV infusion rate: 0.05-5 mcg/kg/minute according to indications and responses. Maintenance of reduced blood pressure during surgery: 1-5 mcg/kg/minute. Emergent treatment for hypertension during surgery: 0.5-5 mcg/kg/minute. Acute heart failure (including the acute exacerbation period of chronic heart failure): Initially 0.05-0.1 mcg/kg/minute, then increase drip rate to 0.1-0.2 mcg/kg/minute every 5-15 minutes until desired response is obtained.                                                                                                                                                                                                        |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| Contraindications  | Acute circulatory failure or shock. Allergy to corn or corn products; IV may contain dextrose. Concomitant use of phosphodiesterase type 5 (PDE-5) inhibitors such as sildenafil, tadalafil, vardenafil, or avanafil. Concomitant riociguat use or other soluble guanylate cyclase inhibitors. Constrictive pericarditis when administered via IV route. Early myocardial infarction associated with SL tablets. Hypersensitivity to nitroglycerin or any component of the product as well as other nitrates or nitrites. Increased intracranial pressure. Pericardial tamponade when administered via IV route. Restrictive cardiomyopathy when administered via IV route. Severe anemia. Narrow-angle glaucoma. |
| Adverse Effects    | Tachycardia, arrhythmia, sudden drop of BP, deterioration of cardiac output, methemoglobinemia, headache, nausea, vomiting. Cardiovascular: Hypotension Dermatologic: Erythroderma, Flushing, Rash Neurologic: Headache (63% ), Lightheadedness (6% )                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Pregnancy          | Human Data Suggest Low Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| More Info          | [UpToDate](https://www.uptodate.com/contents/nitroglycerin-glyceryl-trinitrate-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |

## Nitrostat (NTG) 0.6mg

| TAH Drug Code      | [ONTG6](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=ONTG6)                                                                                                                                                                                                                                                                                                                       |
|:-------------------|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Treatment & prophylaxis of angina pectoris.                                                                                                                                                                                                                                                                                                                                                  |
| Dosing             | Angina pectoris, acute: 0.6 mg sublingually or buccally at 1st sign of acute attack, may be repeated every 5 minutes for 3 doses. If no relief after taking 3 doses within 15 minutes, seek medical attention promptly. Angina pectoris, prophylaxis: 0.6 mg sublingually or buccally 5-10 minutes prior to the activity which may precipitate an attack.                                    |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                |
| Contraindications  | Acute circulatory failure or shock. Concomitant use of phosphodiesterase type 5 (PDE-5) inhibitors such as sildenafil, tadalafil, vardenafil, or avanafil. Concomitant riociguat use or other soluble guanylate cyclase inhibitors. Hypersensitivity to nitroglycerin or any component of the product as well as other nitrates or nitrites. Increased intracranial pressure. Severe anemia. |
| Adverse Effects    | Headache, vertigo, weakness, palpitation & postural hypotension. Marked sensitivity to the hypotensive effects of nitrates (manifested by nausea, vomiting, weakness, diaphoresis, pallor & collapse). Flushing, drug rash & exfoliative dermatitis. Cardiovascular: Hypotension Dermatologic: Erythroderma, Flushing, Rash Neurologic: Headache (63% ), Lightheadedness (6% )               |
| Pregnancy          | Human Data Suggest Low Risk                                                                                                                                                                                                                                                                                                                                                                  |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                                |
| More Info          | [UpToDate](https://www.uptodate.com/contents/nitroglycerin-glyceryl-trinitrate-drug-information)                                                                                                                                                                                                                                                                                             |

